Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:LMNS
Previous Symbol
CUSIPN/A
Phone+972-4-9599000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Lumenis (NASDAQ:LMNS) Frequently Asked Questions
What is Lumenis' stock symbol?
Lumenis trades on the NASDAQ under the ticker symbol "LMNS."
How were Lumenis' earnings last quarter?
Lumenis Ltd (NASDAQ:LMNS) announced its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.05. The medical equipment provider had revenue of $68.51 million for the quarter, compared to analyst estimates of $68.36 million. Lumenis's quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.07 earnings per share. View Lumenis' Earnings History.
Has Lumenis been receiving favorable news coverage?
News coverage about LMNS stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Lumenis earned a news impact score of 1.3 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.
Who are Lumenis' key executives?
Lumenis' management team includes the folowing people:
- Harel Beit-On, Chairman of the Board (Age 52)
- Zipora Ozer-Armon, Chief Executive Officer (Age 51)
- Ophir Yakovian, Chief Financial Officer
- Qiying Zhai, Senior Vice President and Regional President, Lumenis China
- Eran Cohen, Vice President - Global Operations (Age 57)
- Elad Benjamin, Vice President and General Manager - Surgical Strategic Business Unit
- Hadas Padan, Vice President and General Manager Vision Strategic Business Unit
- Roy Ramati, Vice President, General Manager - Aesthetic Strategic Business Unit
- Kfir Azoulay, Vice President - Corporate Marketing
- Ido Ben-Tov, Vice President - Service
How do I buy shares of Lumenis?
Shares of LMNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Lumenis' official website?
How can I contact Lumenis?
Lumenis' mailing address is Hakidma 6 Yokneam Industrial Park P.O.B. # 240, YOKNEAM, 2069204, Israel. The medical equipment provider can be reached via phone at +972-4-9599000.
MarketBeat Community Rating for Lumenis (NASDAQ LMNS)
MarketBeat's community ratings are surveys of what our community members think about Lumenis and other stocks. Vote "Outperform" if you believe LMNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
